Login
$DBGI
$0.98 -$0.02 (2.43%) Pre-market

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q1 FY2025
As of Apr 4, 2025
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Nonrelated party
Related Party
Total accounts receivable, net
Due from factor, net
Inventory
Prepaid expenses and other current assets
Total current assets
Property, equipment and software, net
Right of use asset
Goodwill
Intangible assets, net
Deposits
Prepaid marketing expenses
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other liabilities
Due to related parties
Related Party
Total due to related parties
Convertible note payable, net
Right of use liability, current portion
Accrued interest payable
Loan payable, current
Stock payable
Promissory note payable
Note payable, current
Total current liabilities
Total share-based payment liability
Loans payable
Right of use liability, net of current portion
Notes payable non-current
Deferred tax liability
Total liabilities
Stockholders’ equity:
Preferred stock value
Series A Convertible Preferred Stock
Series C Convertible Preferred Stock
Series D Convertible Preferred Stock
Common stock, $0.0001 par, 1,000,000,000 shares authorized, 547,534 and 219,708 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common Stock
Total common stock, $0.0001 par, 1,000,000,000 shares authorized, 547,534 and 219,708 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock to be issued
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support